Despite their ability to dampen hyperactive WNT and suppress tumor growth in model systems, TNKS inhibitors do not always show anti-proliferative effects as single agents in human CRC cell lines[17, 19, 20]. The gene discussed is TNKS; the disease is colorectal carcinoma.